Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP620794.RAl35QnZ3yH7jTAnRFlIXcBRXbAg4UF-3VH-Va-HKTELs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP620794.RAl35QnZ3yH7jTAnRFlIXcBRXbAg4UF-3VH-Va-HKTELs130_assertion type Assertion NP620794.RAl35QnZ3yH7jTAnRFlIXcBRXbAg4UF-3VH-Va-HKTELs130_head.
- NP620794.RAl35QnZ3yH7jTAnRFlIXcBRXbAg4UF-3VH-Va-HKTELs130_assertion description "[MC1R Arg(160)/Arg(160) homozygotes were at increased risk (P = 0.027, odds ratio = 1.94) while TYR A2/A2 homozygotes were at reduced risk of prostate cancer (P = 0.033, odds ratio = 0.48).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620794.RAl35QnZ3yH7jTAnRFlIXcBRXbAg4UF-3VH-Va-HKTELs130_provenance.
- NP620794.RAl35QnZ3yH7jTAnRFlIXcBRXbAg4UF-3VH-Va-HKTELs130_assertion evidence source_evidence_literature NP620794.RAl35QnZ3yH7jTAnRFlIXcBRXbAg4UF-3VH-Va-HKTELs130_provenance.
- NP620794.RAl35QnZ3yH7jTAnRFlIXcBRXbAg4UF-3VH-Va-HKTELs130_assertion SIO_000772 11720436 NP620794.RAl35QnZ3yH7jTAnRFlIXcBRXbAg4UF-3VH-Va-HKTELs130_provenance.
- NP620794.RAl35QnZ3yH7jTAnRFlIXcBRXbAg4UF-3VH-Va-HKTELs130_assertion wasDerivedFrom befree-20140225 NP620794.RAl35QnZ3yH7jTAnRFlIXcBRXbAg4UF-3VH-Va-HKTELs130_provenance.
- NP620794.RAl35QnZ3yH7jTAnRFlIXcBRXbAg4UF-3VH-Va-HKTELs130_assertion wasGeneratedBy ECO_0000203 NP620794.RAl35QnZ3yH7jTAnRFlIXcBRXbAg4UF-3VH-Va-HKTELs130_provenance.